Zobrazeno 1 - 10
of 16
pro vyhledávání: '"J C, Knutson"'
Autor:
C. W. Bishop, J. C. Knutson, A. U. Tan, J. W. Coburn, B. S. Levine, R. B. Mazess, D. M. Kyllo
Publikováno v:
Nephrology Dialysis Transplantation. 11:153-157
Calcitriol is effective in suppressing PTH levels in haemodialysis patients with hyperparathyroidism but has a low therapeutic index. There is a search for other vitamin D sterols that suppress PTH but cause less hypercalcaemia. We review evidence th
Publikováno v:
Endocrinology. 136:4749-4753
The vitamin D analog 1 alpha-hydroxyvitamin D2 (1 alpha-OHD2) is under development for the treatment of secondary hyperparathyroidism and metabolic bone disease. This analog is metabolized in vivo to the natural active dihydroxylated metabolite of vi
Autor:
J C Knutson, R M Moriarty, C W Bishop, L W LeVan, Stephen Strugnell, R Gilardi, Glenville Jones, Valarie Byford, Hugh L.J. Makin
Publikováno v:
Biochemical Journal. 310:233-241
A major metabolite of the vitamin D analogue 1 alpha-hydroxyvitamin D2 in human liver cells in culture has been identified as 1 alpha,24(S)-dihydroxyvitamin D2 [1 alpha,24(S)-(OH)2D2]. 1 alpha-Hydroxyvitamin D3 incubated with the same cells gives ris
Autor:
S. A. Strugnell, Omar Akhouayri, J. C. Knutson, Alice Arabian, René St-Arnaud, Vionnie W.C. Yu
Publikováno v:
Journal of endocrinological investigation. 31(8)
Background: Vitamin D compounds are effective in managing elevated PTH levels in secondary hyperparathyroidism (SHPT) of renal failure. However, undesired increases in serum calcium and phosphorus associated with compounds such as calcitriol [1,25(OH
Publikováno v:
Anticancer research. 25(6B)
Active vitamin D compounds have been developed that maintain antiproliferative properties with low calcemic activity. BCI-210, a novel vitamin D pro-drug developed in our laboratory, is activated through side chain hydroxylation and possesses lower c
Publikováno v:
Anticancer research. 25(3B)
Bisphosphonates have proven to be effective in the management of multiple myeloma and bone metastases secondary to breast and prostate carcinoma. Vitamin D compounds are important modulators of cellular proliferation and differentiation. 1,24(S)-dihy
Publikováno v:
Anticancer research. 24(5A)
Vitamin D compounds are important modulators of cellular proliferation and differentiation, with potential utility as anticancer drugs. 1,24(S)-Dihydroxyvitamin D2 [1,24(OH)2D2] is a naturally occurring active vitamin D compound with low calcemic act
Publikováno v:
Anticancer research. 18(3A)
The physiologically active metabolite of the vitamin D seco-steroid hormone, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), is a major regulator of mineral homeostasis. Recent evidence also suggests its role in regulating proliferation and differentiation o
Autor:
E B, Mawer, G, Jones, M, Davies, P E, Still, V, Byford, N J, Schroeder, H L, Makin, C W, Bishop, J C, Knutson
Publikováno v:
The Journal of clinical endocrinology and metabolism. 83(6)
We have produced evidence for a new metabolic pathway for vitamin D2 in humans involving the production of 24-hydroxyvitamin D2 (24OHD2) and 1,24-dihydroxyvitamin D2 [1,24-(OH)2D2]. These metabolites were produced after either a single large dose (10
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 11
Calcitriol is effective in suppressing PTH levels in haemodialysis patients with hyperparathyroidism but has a low therapeutic index. There is a search for other vitamin D sterols that suppress PTH but cause less hypercalcaemia. We review evidence th